ESMO contributes to discussions on the future of cancer care at EU Cancer Mission event By Ogkologos - October 7, 2026 42 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Non-pharmacological interventions – are they important to patients with cancer? Two novel bispecific antibodies in combination with chemotherapy show efficacy in neuroendocrine carcinomas Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small cell lung cancer MOST POPULAR More Evidence that One HPV Vaccine Dose Protects against Cancer-Causing Infections June 3, 2022 Why it’s difficult to estimate the number of extra cancer deaths... July 21, 2020 Ellen Gifts 25K To Army Veteran Who Fought Breast Cancer And... November 18, 2019 EMA Starts Review of Rucaparib May 19, 2022 Load more HOT NEWS Copanlisib Shows Promising Clinical Activity in Select Tumours with PIK3CA Mutation... ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research,... FDA Approves Zanubrutinib for Waldenström’s Macroglobulinemia EMA Recommends Extension of Therapeutic Indications for Ibrutinib
